Skip to main content

Main menu

  • HOME
  • ARTICLES
    • Current Issue
    • Abstracts In Press
    • Archives
    • Special Issue Archive
    • Subject Collections
  • INFO FOR
    • Authors
    • Reviewers
    • Call For Papers
    • Subscribers
    • Advertisers
  • SUBMIT
    • Manuscript
    • Peer Review
  • ABOUT
    • The JABFM
    • The Editing Fellowship
    • Editorial Board
    • Indexing
    • Editors' Blog
  • CLASSIFIEDS
  • Other Publications
    • abfm

User menu

Search

  • Advanced search
American Board of Family Medicine
  • Other Publications
    • abfm
American Board of Family Medicine

American Board of Family Medicine

Advanced Search

  • HOME
  • ARTICLES
    • Current Issue
    • Abstracts In Press
    • Archives
    • Special Issue Archive
    • Subject Collections
  • INFO FOR
    • Authors
    • Reviewers
    • Call For Papers
    • Subscribers
    • Advertisers
  • SUBMIT
    • Manuscript
    • Peer Review
  • ABOUT
    • The JABFM
    • The Editing Fellowship
    • Editorial Board
    • Indexing
    • Editors' Blog
  • CLASSIFIEDS
  • JABFM on Bluesky
  • JABFM On Facebook
  • JABFM On Twitter
  • JABFM On YouTube

Induction of Medication for Opioid Use Disorder in Primary Care

ORIGINAL RESEARCH

Tristen L. Hall, PhD, MPH; Douglas H. Fernald, MA; Vivian Jiang, MD; Kristen Curcija, MPH; Joseph W. LeMaster, MD, MPH; John (Jack) M. Westfall, MD, MPH; Donald E. Nease, Jr., MD; Linda Zittleman, MSPH

Corresponding Author: Tristen L. Hall, PhD, MPH; Department of Family Medicine, University of Colorado Anschutz Medical Campus 

Email: Tristen.Hall@cuanschutz.edu

DOI: 10.3122/jabfm.2024.240317R1

Keywords: Buprenorphine, Opioid Use Disorder, Opioids, Primary Health Care, Qualitative Research, Social Determinants of Health, Telemedicine

Dates: Submitted: 08-23-2024; Revised: 10-30-2024; 11-06-2024; Accepted: 01/13/2025

Status: In production for ahead of print. 

BACKGROUND: Overdoses and deaths from synthetic opioids grew sharply in the past decade. Most people with opioid use disorder (OUD) do not receive recommended evidence-based treatment: nationally, 72% to 87% of people who need OUD treatment do not receive medication for opioid use disorder (MOUD). Little is known about practice teams’ experiences with home, office, and telehealth induction for MOUD, particularly in primary care.

METHODS: We conducted semi-structured interviews with primary care clinicians and staff from February through September 2023 to understand experiences providing MOUD via home, office, and telehealth induction. Interviews were part of a PCORI-funded trial, Home vs. Office vs. telehealth for Medication Enhanced Recovery (HOMER). We used template and editing coding styles to categorize text according to deductive codes derived from research questions and inductive codes derived from multiple readings of transcripts. We used immersion-crystallization to iteratively review coded text and identify interview themes.

RESULTS: Thirty-eight clinicians and staff from 21 US primary care practices participated in interviews. Home induction is increasingly common and preferred by patients and practice teams, social determinants of health affect induction and maintenance in treatment, clinicians and staff use honest communication to build trusting relationships with patients, practices identified patients as MOUD candidates through word-of-mouth and referrals, and an evolving OUD landscape are causing practices to adapt their care.

CONCLUSION: Primary care practices are committed to offering MOUD. Findings offer insights about the challenges facing primary care practices in their efforts to deliver MOUD to address a rapidly evolving opioid epidemic.

ABSTRACTS IN PRESS

Navigate

  • Home
  • Current Issue
  • Past Issues

Authors & Reviewers

  • Info For Authors
  • Info For Reviewers
  • Submit A Manuscript/Review

Other Services

  • Get Email Alerts
  • Classifieds
  • Reprints and Permissions

Other Resources

  • Forms
  • Contact Us
  • ABFM News

© 2025 American Board of Family Medicine

Powered by HighWire